The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction


Paitazoglou C., ÖZDEMİR R., Pfister R., Bergmann M. W. , Bartunek J., KILIÇ T. , et al.

EUROINTERVENTION, cilt.15, ss.403-410, 2019 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 15 Konu: 5
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4244/eij-d-19-00342
  • Dergi Adı: EUROINTERVENTION
  • Sayfa Sayısı: ss.403-410

Özet

Aims: Reducing elevated left atrial pressure with an atrial septum shunt device is a possible treatment option in symptomatic heart failure patients. This study aimed to investigate the safety and feasibility of the Atrial Flow Regulator (AFR) in heart failure patients.